Proceedings of the National Academy of Sciences · 2007 · 237 citations · 28 references
Life SciencesBiochemistryPhysiologyCell SignalingPathophysiologySignal TransductionCardiovascular PhysiologyGastrointestinal PathophysiologyBlood PressureGastrointestinal Tract ObstructionGuanylyl Cyclase RegulationIntestinal DysmotilityNitric OxideNitric Oxide SignalingPlatelet Aggregation DefectsSmooth Muscle Contraction
The signaling molecule nitric oxide (NO), first described as endothelium-derived relaxing factor (EDRF), acts as physiological activator of NO-sensitive guanylyl cyclase (NO-GC) in the cardiovascular, gastrointestinal, and nervous systems. Besides NO-GC, other NO targets have been proposed; however, their particular contribution still remains unclear. Here, we generated mice deficient for the beta1 subunit of NO-GC, which resulted in complete loss of the enzyme. GC-KO mice have a life span of 3-4 weeks but then die because of intestinal dysmotility; however, they can be rescued by feeding them a fiber-free diet. Apparently, NO-GC is absolutely vital for the maintenance of normal peristalsis of the gut. GC-KO mice show a pronounced increase in blood pressure, underlining the importance of NO in the regulation of smooth muscle tone in vivo. The lack of an NO effect on aortic relaxation and platelet aggregation confirms NO-GC as the only NO target regulating these two functions, excluding cGMP-independent mechanisms. Our knockout model completely disrupts the NO/cGMP signaling cascade and provides evidence for the unique role of NO-GC as NO receptor.
28
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Paul L. Huang, Zhihong Huang, Hiroshi Mashimo et al. · Nature · 1995 · 2.1K citations
Life Sciences, Genetics, Physiology +12
Targeted disruption of the neuronal nitric oxide synthase gene
Paul L. Huang, Ted M. Dawson, David S. Bredt et al. · Cell · 1993 · 1.3K citations